home / stock / aplt / aplt news


APLT News and Press, Applied Therapeutics Inc. From 05/08/25

Stock Information

Company Name: Applied Therapeutics Inc.
Stock Symbol: APLT
Market: NASDAQ
Website: appliedtherapeutics.com

Menu

APLT APLT Quote APLT Short APLT News APLT Articles APLT Message Board
Get APLT Alerts

News, Short Squeeze, Breakout and More Instantly...

APLT - Expected US Company Earnings on Thursday, May 8th, 2025

Ironwood Pharmaceuticals Inc. (IRWD) is expected to report $-0.05 for Q1 2025 CaliberCos Inc. (CWD) is expected to report $-0.4 for Q1 2025 BlackRock TCP Capital Corp. (TCPC) is expected to report $0.34 for Q1 2025 INmune Bio Inc. (INMB) is expected to report $-0.43 for Q1 2025 No...

APLT - Applied Therapeutics GAAP EPS of -$0.76 beats by $0.57, revenue of $0.5M misses by $0.05M

2025-04-14 17:52:53 ET More on Applied Therapeutics Seeking Alpha’s Quant Rating on Applied Therapeutics Historical earnings data for Applied Therapeutics Financial information for Applied Therapeutics Read the full article on Seeking Alpha For...

APLT - Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results

-  Appointed John H. Johnson as Executive Chairman; Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer; and Reena Thomas Colacot as Vice President and Head of Quality NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company&...

APLT - Expected US Company Earnings on Wednesday, April 2nd, 2025

Global Gas Corporation (HGAS) is expected to report for Q4 2024 ABVC BioPharma Inc. (ABVC) is expected to report for quarter end 2024-12-31 Medalist Diversified REIT Inc. (MDRR) is expected to report for quarter end 2024-12-31 Healthier Choices Management Corp (HCMC) is expected to re...

APLT - APLT - Historical Earnings Price Analysis

2025-04-01 18:44:30 ET Applied Therapeutics, Inc. (APLT) earnings is schedule to release on 2025-04-02. Following Earnnigs Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in APLT stock price following earnings has...

APLT - Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today anno...

APLT - Expected US Company Earnings on Wednesday, March 26th, 2025

Nu Ride Inc. - Class A (NRDE) is expected to report for quarter end 2024-12-31 Dalrada Financial Corp. (DFCO) is expected to report for quarter end 2024-12-31 HilleVax Inc. (HLVX) is expected to report $-0.38 for Q4 2024 Chewy Inc. Class A (CHWY) is expected to report $0.03 for Q4 202...

APLT - Expected US Company Earnings on Wednesday, March 19th, 2025

Churchill Capital Corp IX (CCIX) is expected to report for quarter end 2024-12-31 Worthington Steel Inc. (WS) is expected to report $0.67 for Q3 2025 General Mills Inc. (GIS) is expected to report $0.95 for Q3 2025 Talphera Inc. (TLPH) is expected to report for Q4 2024 Sensei Biot...

APLT - Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer

NEW YORK, March 19, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced the appointment of Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer. Dr. Baumgartner will s...

APLT - Expected US Company Earnings on Wednesday, March 12th, 2025

Portage Biotech Inc. (PRTG) is expected to report for Q3 2025 Aimei Health Technology Co. Ltd (AFJK) is expected to report for quarter end 2024-12-31 Generation Bio Co. (GBIO) is expected to report $-0.28 for Q4 2024 TAT Technologies Ltd. (TATT) is expected to report for quarter end 2...

Previous 10 Next 10